The “Cytokine Storm” and Inflammatory Response to SARS-CoV-2

SARS-CoV-2 infection in patients has shown increased secretion of IL-1β, IFN-γ, IP-10/CXCL10, MCP-1/CCL2, IL-4, and IL-10. In addition, the infection has shown elevated levels of inflammatory cytokines such as IL-2, IL-6, IL-7, IL-10, G-CSF, IP-10/CXCL10, MCP-1/CCL2, MIP-1A, and TNF-α generating possible “cytokine storm”1,2. The treatment of cytokine storm has become increasingly important in helping coronavirus patients. Studies have shown that the IL-6R (Interleukin-6 Receptor) plays an important role in alleviating Cytokine Release Syndrome (CRS)2. While causes for inflammatory responses remain widely unknown, Leinco can assist researchers in providing many of these cytokines.

SARS-CoV-2 Increased Secretion & Inflammation of CytokinesSARS-CoV-2 Cytokine Response

Cytokines

- -
- -
Product
Clone
Applications
Prod No.
Package Size
T376
10 µg
50 µg
G596
25 µg
5 µg
R1365
1 mg
100 µg
500 µg
I-223
100 µg
I-812
1 mg
100 µg
25 µg
500 µg
I-525
25 µg
I-212
10 µg
50 µg
I-279
10 µg
50 µg
I-221
25 µg
5 µg
I-213
10 µg
50 µg
1456

Antibodies to Cytokines

Additional conjugates available for each. 

- -
- -
Product
Clone
Applications
Prod No.
Package Size
JES5-2A5
CyTOF®
in vivo
N
WB
I-1152
0.5 mg
1.0 mg
N
WB
I-330
100 µg
25 µg
C17.8
ELISA
ICFC
in vivo
IP
N
WB
I-1175
1.0 mg
100 mg
25 mg
5 mg
50 mg
201136
ELISA Cap
WB
I-882
100 µg
25 µg
500 µg
IHC FF
N
WB
I-404
100 µg
25 µg
50101
ELISA Cap
WB
I-699
100 µg
25 µg
500 µg
30311
ELISA Cap
N
I-659
100 µg
25 µg
500 µg
ELISA Indirect
IHC FF
N
WB
I-162
100 µg
25 µg
B122
in vivo
IP
N
WB
I-437
1.0 mg
100 mg
25 mg
5.0 mg
50 mg
JES6-5H4
IHC FFPE
IP
I-1039
0.5 mg
14568

ELISA Development Kits

- -
- -
No results found. Clear filters and try again?
  1. Y. Fu, et al. 2020, Virologica Sinica, 35:266–271
  2. C. Zhang, et al. 2020, International Journal of Antimicrobial Agents, 105954
  3. Image: G. Schett, et al. 2020, Nat Rev Immunol20, 271–272.